Project Grant S10OD038273

Award Date 8/1/25
Completion Date 7/1/26
Dollars Obligated $2M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Institutes of Health Office of the Director awarded Stanford University $3.8 million under the Research Infrastructure Programs grant program (CFDA 93.351) to acquire a new Orbitrap Tribrid mass spectrometry platform. For over 20 years, Stanford University Mass Spectrometry has served as the campus-wide shared proteomics resource, housing and maintaining mass spectrometry instruments to support numerous NIH-funded biomedical research projects spanning human development, degenerative...
The National Institutes of Health (NIH) awarded a $1,352,820 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the Massachusetts General Hospital (MGH) to acquire a novel high-throughput and high-sensitivity mass spectrometer called the Orbitrap Astral. This state-of-the-art instrument will be used to conduct proteomic research focused on cancer and Alzheimer's disease at MGH. The Orbitrap Astral's unprecedented speed and sensitivity are expected to enable new...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $1,658,828 to the Medical University of South Carolina (MUSC) to acquire a Thermo Scientific Orbitrap Astral Mass Spectrometer. This state-of-the-art mass spectrometry instrument will support NIH-funded research across multiple disease areas, including cancer, immunotherapy, cardiovascular disease, liver and digestive...
This $1,574,994 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a high-resolution tandem mass spectrometer to support large molecule structural characterization research at the University of California, Los Angeles (UCLA). The state-of-the-art mass spectrometer, equipped with electrospray ionization and various activation/dissociation methods, will enable advanced analysis of a broad range of...
The National Science Foundation Office of Integrative Activities awarded a $1,179,143 Project Grant to the University of New Hampshire (UNH) to acquire an Orbitrap Eclipse Tribrid mass spectrometer. This equipment will (i) dramatically improve UNH's mass spectrometry capabilities to expedite diverse research projects, (ii) facilitate hands-on training and inquiry-based learning on modern instrumentation, and (iii) establish a regional high-resolution mass spectrometry facility. The funding...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $738,090 to the University of California, Irvine (UCI) to purchase a refurbished Orbitrap Eclipse Tribrid mass spectrometer. The new instrument will enable a major user group at UCI to conduct enhanced quantitative protein-based mass spectrometry experiments in support of multiple NIH-funded research programs. Key applications include...
This $949,116 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This cutting-edge analytical instrumentation will establish a unique omics capability at USF to support detailed, high-resolution structural analysis of low-level small molecules in complex...
This $1,205,941.00 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will enable the Salk Institute for Biological Studies to acquire a high-resolution Thermo Fisher Scientific Orbitrap IQ-X Tribrid mass spectrometer. This cutting-edge instrument with an ultrahigh performance liquid chromatography system will significantly enhance the Institute's mass spectrometry capabilities, allowing for more...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $750,000 to Stanford University to acquire a Bruker timsTOF Flex MALDI-2 mass spectrometer. The instrument will be used to support spatial single-cell omics research at Stanford's Center for Genomics and Personalized Medicine. This state-of-the-art mass spectrometer will enable researchers to study the spatial distribution of small molecules, such as...
This $1,077,584 Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) will fund the purchase of a Bruker timsTOF HT mass spectrometer and supporting liquid chromatography equipment for the Center for Advanced Proteomics Research (CAPR) at Rutgers University-Newark. The new mass spectrometry system will enable CAPR to significantly expand its proteomics research capabilities and support a major user group of 15 NIH-funded investigators...

This Project Grant award of $1,980,309 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) under CFDA 93.351 will fund the acquisition of an Orbitrap Astral mass spectrometer system for the Keck MS & Proteomics Resource at Yale University. The advanced instrument will enable rapid, high-resolution protein identification and quantification, supporting a wide range of proteomics research projects across Yale and external investigators. Key expected capabilities include the ability to identify over 9,000 proteins in a 15-minute liquid chromatography gradient, substantially increasing sample throughput and depth of coverage compared to the resource's current instrumentation. This investment will equip the Keck facility with state-of-the-art mass spectrometry capabilities to accommodate increased demand from over 142 Yale and non-Yale investigators, driving advances in areas such as biomarker discovery, single-cell proteomics, and the study of post-translational modifications. The award has strong institutional support, with over $227,000 committed towards long-term service and maintenance costs.

Generated 8/5/25, 5:21 AM